Molecular docking studies were conducted to evaluate the interactions between fatty acid amides (FAAs) and cannabinoid receptors CB1 and CB2, both of which are relevant in breast cancer due to their role in tumor progression and the endocannabinoid system. This evidence concerns the gene CNR2 and breast cancer.